Acumen Pharmaceuticals, Inc. - Multiplikator EV/Sales ABOS

Logo perusahaan publik acumenpharm.com (ABOS)

The Alzheimer's disease therapy market possesses colossal sales potential, as confirmed by the upward trend of the EV/Sales ratio, where the value is fixed at 0.00. Acumen Pharmaceuticals (ABOS) relies on the creation of a targeted antibody system for patient retention. However, capitalization depends on drug safety and the ability to compete with industry behemoths.

Acumen Pharmaceuticals - Rasio nilai perusahaan marang pendapatan ABOS (periode 23.11.2025 - 20.11.2026)

Acumen Pharmaceuticals, Inc - rincian analitis lan metrik utama (ABOS)

Pambiji fundamental perusahaan:ABOS, Acumen Pharmaceuticals, Inc.
Produk seri Acumen Pharma

The development of Alzheimer's immunotherapy with the potential for multi-year patent rents makes Acumen Pharmaceuticals (ABOS) a high-risk asset with deferred revenue. The EV/Sales ratio (debt-adjusted) measures the total business value relative to its operating income, allowing for an assessment of market expectations regarding future cash flows. By analyzing the company's current enterprise value to sales, an investor can determine whether a low valuation represents an undervaluation or a signal of business stagnation.

Pesaing langsung

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE